Efficacy of mesenchymal stromal cells and cellular products in improvement of symptoms for COVID‐19 and similar lung diseases-Reference-Cited by-同舟云学术

Efficacy of mesenchymal stromal cells and cellular products in improvement of symptoms for COVID‐19 and similar lung diseases

Published:2021-03-27 Issue:6 Volume:118 Page:2168-2183
ISSN:0006-3592
Container-title:Biotechnology and Bioengineering
language:en
Short-container-title:Biotechnology and Bioengineering

Author:

Banimohamad‐Shotorbani Behnaz¹²^ORCID,Farajpour Hekmat³,Sefat Farshid⁴⁵^ORCID,Khosroshahi Shiva Ahdi⁶^ORCID,Shafaei Hajar²⁷^ORCID,Heidari keshel Saeed³^ORCID

Affiliation:

1. Student Research Committee University of Medical Sciences Tabriz Iran

2. Department of Tissue Engineering, Faculty of Advanced Medical Sciences Tabriz University of Medical Sciences Tabriz Iran

3. Department of Tissue Engineering and Applied Cell Sciences, School of Advanced Technologies in Medicine Shahid Beheshti University of Medical Sciences Tehran Iran

4. Department of Biomedical and Electronics Engineering, School of Engineering University of Bradford Bradford UK

5. School of Engineering, Interdisciplinary Research Center in Polymer Science & Technology (Polymer IRC) University of Bradford Bradford UK

6. Department of Medical Biotechnology, Faculty of Advanced Medical Sciences Tabriz University of Medical Sciences Tabriz Iran

7. Department of Anatomical Sciences, Faculty of Medicine Tabriz University of Medical Sciences Tabriz Iran

Publisher

Wiley

Subject

Applied Microbiology and Biotechnology,Bioengineering,Biotechnology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/bit.27729

Reference111 articles.

1. International Society for Extracellular Vesicles and International Society for Cell and Gene Therapy statement on extracellular vesicles from mesenchymal stromal cells and other cells: considerations for potential therapeutic agents to suppress coronavirus disease-19

2. Mesenchymal stem cells for the prevention of bronchopulmonary dysplasia: delivering the secretome;Abman S. H.;ATS Journal,2009

3. Mesenchymal stem cell-derived extracellular vesicles for the treatment of acute respiratory distress syndrome

4. COVID‐19 therapy with mesenchymal stromal cells (MSC) and convalescent plasma must consider exosome involvement: Do the exosomes in convalescent plasma antagonize the weak immune antibodies?

5. Bone Marrow Stromal Cells Attenuate Lung Injury in a Murine Model of Neonatal Chronic Lung Disease

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effectiveness and safety profile of mesenchymal stem cell secretome as a treatment for severe cases of COVID-19: a randomized controlled trial;F1000Research;2022-07-25

2. Effectiveness and safety profile of mesenchymal stem cell secretome as a treatment for severe cases of COVID-19: a randomized controlled trial;F1000Research;2022-02-03